Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer

BACKGROUND: Nanoparticle albumin-bound paclitaxel (nab-PTX), which avoids toxicities associated with a vehicle used in solvent-based PTX, has already shown safety and efficacy in patients with non-small cell lung cancer (NSCLC). METHODS: A phase II study was performed to assess the safety and effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Anzai, Masaki, Morikawa, Miwa, Okuno, Takehiro, Umeda, Yukihiro, Demura, Yoshiki, Sonoda, Tomoaki, Yamaguchi, Makiko, Kanno, Kiyoshi, Shiozaki, Kohei, Ameshima, Shingo, Akai, Masaya, Ishizuka, Tamotsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758208/
https://www.ncbi.nlm.nih.gov/pubmed/29390506
http://dx.doi.org/10.1097/MD.0000000000009320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758208/
https://www.ncbi.nlm.nih.gov/pubmed/29390506
http://dx.doi.org/10.1097/MD.0000000000009320

Ejemplares similares